Tags

Type your tag names separated by a space and hit enter

Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
Semin Thromb Hemost. 2020 10; 46(7):853-855.ST

Authors+Show Affiliations

Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.Anesthesiology Department & Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran. Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32557449

Citation

Dorgalaleh, Akbar, et al. "Patients With Congenital Bleeding Disorders Appear to Be Less Severely Affected By SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?" Seminars in Thrombosis and Hemostasis, vol. 46, no. 7, 2020, pp. 853-855.
Dorgalaleh A, Dabbagh A, Tabibian S, et al. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)? Semin Thromb Hemost. 2020;46(7):853-855.
Dorgalaleh, A., Dabbagh, A., Tabibian, S., Baghaeipour, M. R., Jazebi, M., Bahraini, M., Fazeli, S., Rad, F., & Baghaeipour, N. (2020). Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)? Seminars in Thrombosis and Hemostasis, 46(7), 853-855. https://doi.org/10.1055/s-0040-1713435
Dorgalaleh A, et al. Patients With Congenital Bleeding Disorders Appear to Be Less Severely Affected By SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2020;46(7):853-855. PubMed PMID: 32557449.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)? AU - Dorgalaleh,Akbar, AU - Dabbagh,Ali, AU - Tabibian,Shadi, AU - Baghaeipour,Mohammad Reza, AU - Jazebi,Mohammad, AU - Bahraini,Mehran, AU - Fazeli,Sahar, AU - Rad,Fariba, AU - Baghaeipour,Nazanin, Y1 - 2020/06/18/ PY - 2020/6/20/pubmed PY - 2020/10/31/medline PY - 2020/6/20/entrez SP - 853 EP - 855 JF - Seminars in thrombosis and hemostasis JO - Semin Thromb Hemost VL - 46 IS - 7 SN - 1098-9064 UR - https://www.unboundmedicine.com/medline/citation/32557449/Patients_with_Congenital_Bleeding_Disorders_Appear_to_be_Less_Severely_Affected_by_SARS_CoV_2:_Is_Inherited_Hypocoagulability_Overcoming_Acquired_Hypercoagulability_of_Coronavirus_Disease_2019__COVID_19_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-0040-1713435 DB - PRIME DP - Unbound Medicine ER -